Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, and Lung Cancer Diagnosis and Treatment.
Clinical characteristics and survival analysis of cancer of unknown primary
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
Long Non-coding RNA X-Inactive Specific Transcript Promotes Esophageal Squamous Cell Carcinoma Progression via the MicroRNA 34a/Zinc Finger E-box–Binding Homeobox 1 Pathway
Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis
SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis
Correlation Analysis between T790M Status and Clinical Characteristicsof Patients with EGFR-sensitive Mutation Advanced NSCLC whoProgressed after the First Generation and First-line EGFR-TKIsAdministration: A Real-world Exploratory Study
Prognostic value of neutrophil to lymphocyte ratio and platelet counts during chemotherapy in patients with advanced gastric cancer
Distal-continual colon interposition for esophageal reconstruction after esophagectomy: Two case reports
Multivariate analysis of prognostic factors in patients with lung cancer
Comparative clinical analysis of fever in tumor patients, normal patients, and those infected with new coronavirus pneumonia
LncRNA XIST promotes metastasis in ESCC by sponging miR-34a to regulate ZEB1 Expression
Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing
Preparation of a Bombyx mori acetylcholinesterase enzyme reagent through chaperone protein disulfide isomerase co-expression strategy in Pichia pastoris for detection of pesticides
<p>LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint</p>
Linc‑pint overexpression inhibits the growth of gastric tumors by downregulating HIF‑1α
Survival analysis of anticoagulant treatment of non-small cell lung cancer.